Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02625181
Other study ID # 151750
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 2016
Est. completion date November 30, 2017

Study information

Verified date March 2019
Source Vanderbilt University Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine how automated recommendations are best presented to optimize the adherence to guidelines on prophylaxis for nausea and vomiting after surgery.


Description:

Nausea and vomiting after surgery (PONV) is a common side effect of the surgical procedure, general anesthesia and opioid use occurring in about one third of patients. In addition to being very unpleasant for patients, it is associated with longer recovery room stays and increased costs. Much research has been done on prophylactic interventions that may be applied during the surgical procedure to prevent PONV. Current national guidelines recommend that a risk score is used to decide on the number of prophylactic interventions to administer to a patient. Based on specific characteristics of individual patients and the procedures that they are about to undergo, such a risk score predicts the risk of PONV for each individual. According to the national guidelines, patients with higher risks of PONV should receive more prophylactic interventions. However, in a busy operating room where the anesthesia provider performs multiple patient care tasks, closely following the recommendations to minimize the risk of PONV is often difficult.

Computers may help anesthesia providers to adhere to best practices for PONV prevention by providing so-called decision support. A decision support system for PONV automatically calculates the risk of PONV for an individual patient and presents this predicted risk to the anesthesia provider on the computer screen that is being used by the anesthesia team for record keeping. In recent studies, such decision support systems have been demonstrated to improve adherence to PONV guidelines, especially when a recommendation on the number of interventions is added to the predicted risk. However, in these studies there was still quite some room for improvement of the adherence to PONV guidelines. In general, implementation science is only beginning to understand how such decision support systems are best used to improve medical decision making and minimize practice variations among providers. Further study of how the design of decision support systems impacts the decision making of healthcare providers is therefore warranted.

In this proposed study, the investigators will implement several decision support elements for PONV that aim to help anesthesia providers to adhere to the departmental PONV guidelines during the anesthetic case. The study consists of three phases. The first phase is the preintervention phase - i.e. before the decision support has been implemented. The second phase is the first intervention phase with one CDSS feature added. The third phase is the second intervention phase with another CDSS feature added.

The decision support elements will provide information about the patient's predicted risk of PONV and the number of prophylactic interventions that the departmental guidelines recommend based on that risk. We will start with preoperative email notifications, followed by an element within the anesthesia information management system (AIMS) that are displayed around the start and end of the procedure. All forms of decision support only provide recommendations. The anesthesia provider is free to act on the message or ignore the notifications.

The investigators will compare the adherence to PONV guidelines and the actual occurrence of PONV (both nausea and emetic events: vomiting and retching) in the post-anesthesia care unit (PACU) between all study phases and between the different interventions. The goal of the comparison is to evaluate which decision support elements have an added value to optimize guideline adherence for PONV prophylaxis.


Recruitment information / eligibility

Status Completed
Enrollment 27034
Est. completion date November 30, 2017
Est. primary completion date November 2, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- All adult patients (18 years and older) that are scheduled for an elective surgical procedure under general anesthesia

Exclusion Criteria:

- Patients undergoing emergency surgery or organ transplantation

- Patients that are transferred directly to the Intensive Care Unit after the end of the procedure

- Patients that die intraoperatively

- Procedures that only require a sedative level of anesthesia

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Automated recommendation at the start of the case
The first notification is the main notification that informs the anesthesia providers at the start of anesthesia of the risk score for that individual patient and the recommended number of prophylactic interventions. The notification occurs within the anesthesia information management system (AIMS)
Automated notification at the start of surgery
The second notification within the AIMS will notify the anesthesia providers at the start of surgery when no prophylaxis has been given while three or more interventions were recommended.
Preoperative recommendations: by email
A recommendation on PONV prophylaxis to anesthesia providers through email at the Vanderbilt University Medical Center.
Automated notification at the end of surgery
A notification will remind anesthesia providers at the closing of surgery how many prophylactic interventions are required to adhere to the recommended number of interventions.
Device:
Anesthesia Information Management System (AIMS)
The anesthesia electronic record keeping system
Perioperative Data Warehouse (PDW)
The data warehouse that is used to gather perioperative data and create user reports. In this instance the PDW will be used to send the preoperative emails.
Procedure:
General anesthesia
Any anesthetic drugs that are used to induce general anesthesia above the level of sedation.
Elective surgery
Surgical procedures that are scheduled and not an emergency.
Drug:
Propofol
Anesthetic drug used to maintain general anesthesia
Sevoflurane
Anesthetic drug used to maintain general anesthesia
Isoflurane
Anesthetic drug used to maintain general anesthesia
Desflurane
Anesthetic drug used to maintain general anesthesia
Scopolamine
Prophylactic antiemetic
Droperidol
Prophylactic antiemetic & rescue antiemetic
Haloperidol
Prophylactic antiemetic & rescue antiemetic
Dexamethasone
Prophylactic antiemetic & rescue antiemetic
Promethazine
Prophylactic antiemetic & rescue antiemetic
Meclizine
Prophylactic antiemetic & rescue antiemetic
Aprepitant
Prophylactic antiemetic & rescue antiemetic
Metoclopramide
Rescue antiemetic
Fentanyl
Analgesic drug / Opioid
Sufentanil
Analgesic drug / Opioid
Alfentanil
Analgesic drug / Opioid
Remifentanil
Analgesic drug / Opioid
Morphine
Analgesic drug / Opioid
Meperidine
Analgesic drug / Opioid
Hydromorphone
Analgesic drug / Opioid
Methadone
Analgesic drug / Opioid
Oxycodone
Analgesic drug / Opioid
Oxymorphone
Analgesic drug / Opioid
Hydrocodone
Analgesic drug / Opioid
Ketamine
Analgetic / Analgesic drug
Ondansetron
Prophylactic antiemetic & rescue antiemetic
Granisetron
Prophylactic antiemetic & rescue antiemetic
Dolasetron mesylate
Prophylactic antiemetic & rescue antiemetic
Palonosetron
Prophylactic antiemetic & rescue antiemetic
Tropisetron
Prophylactic antiemetic & rescue antiemetic
Ramosetron
Prophylactic antiemetic & rescue antiemetic

Locations

Country Name City State
United States Vanderbilt University Medical Center Nashville Tennessee

Sponsors (1)

Lead Sponsor Collaborator
Vanderbilt University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Adherence to PONV Guidelines PONV guideline adherence: percentage of patients who received the exact number of prophylactic interventions for PONV that were recommended by the decision support. A specific time frame on the day of surgery: the start of admission at the holding room to the end of the anesthetic case
Secondary PONV Incidence: Number of Participants With Postoperative Nausea and Vomiting The occurrence of PONV, as defined by the administration of antiemetics in the PACU between admission to PACU and discharge from PACU. PACU recovery period
Secondary The Number of Prophylactic Interventions for PONV the absolute number of prophylactic interventions applied between the admission of the patient in the holding room until admission to the PACU. A specific time frame on the day of surgery: from the start of admission at the holding room to the end of the anesthetic case
Secondary Time to Discharge From the Postanesthesia Care Unit (PACU) This is the number of minutes from admission to the PACU until discharge, assessed up to 2 days A specific time frame on the day of surgery: from the start of admission to the PACU to discharge from the PACU
See also
  Status Clinical Trial Phase
Completed NCT04466046 - The Effect on Anxiolytics With Type of Antiemetic Agents on Postoperative Nausea and Vomiting in High Risk Patients
Completed NCT03139383 - Dextrose Containing Fluid and the Postoperative Nausea and Vomiting in the Gynecologic Laparoscopic Surgery N/A
Recruiting NCT04069806 - Preoperative Oral Carbohydrate for Nausea and Vomiting Prevention During Cesarian Section N/A
Completed NCT04043247 - Transcutaneous Electrical Acupoint Stimulation for Prevention of Postoperative Nausea and Vomiting N/A
Terminated NCT01975727 - Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting Phase 2
Completed NCT03662672 - Rib Raising for Post-operative Ileus N/A
Completed NCT00090155 - 2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED) Phase 3
Recruiting NCT05375721 - Prevention of PONV With Traditional Chinese Medicine N/A
Completed NCT02480088 - Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 Polymorphism Phase 4
Recruiting NCT06137027 - Cannabidiol Oil Extract for Prevention of Postoperative Nausea and Vomiting Early Phase 1
Not yet recruiting NCT05529004 - A 6 Months Double Blind Trial to Prevent PONV in Laparoscopic Cholecystectomy Phase 2
Completed NCT02944942 - Risk Factors for Postoperative Nausea/Vomiting N/A
Recruiting NCT02571153 - Low Doses of Ketamine and Postoperative Quality of Recovery Phase 4
Completed NCT02550795 - Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer N/A
Completed NCT02449291 - Study of APD421 as PONV Treatment (no Prior Prophylaxis) Phase 3
Recruiting NCT01442012 - Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting in Ambulatory Surgery N/A
Completed NCT01478165 - Comparison of TIVA (Total Intravenous Anesthesia) and TIVA Plus Palonosetron in Preventing Postoperative Nausea and Vomiting N/A
Unknown status NCT01268748 - Single Port Versus Four Ports Laparoscopic Cholecystectomy and Early Postoperative Pain N/A
Completed NCT02143531 - Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting Phase 4
Completed NCT00734929 - Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy Phase 4